{"protocolSection":{"identificationModule":{"nctId":"NCT00234065","orgStudyIdInfo":{"id":"C02100-002"},"secondaryIdInfos":[{"id":"JapicCTI-050034"},{"id":"UMIN-CTR-C000000129"}],"organization":{"fullName":"Otsuka Pharmaceutical Co., Ltd.","class":"INDUSTRY"},"briefTitle":"Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)","officialTitle":"Post-marketing Study of Cilostazol: Study to Confirm Efficacy in Preventing Recurrent Cerebral Infarction in Comparison With Aspirin"},"statusModule":{"statusVerifiedDate":"2011-06","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2003-12"},"primaryCompletionDateStruct":{"date":"2008-12","type":"ACTUAL"},"completionDateStruct":{"date":"2008-12","type":"ACTUAL"},"studyFirstSubmitDate":"2005-10-04","studyFirstSubmitQcDate":"2005-10-04","studyFirstPostDateStruct":{"date":"2005-10-06","type":"ESTIMATED"},"resultsFirstSubmitDate":"2011-04-19","resultsFirstSubmitQcDate":"2011-04-19","resultsFirstPostDateStruct":{"date":"2011-05-13","type":"ESTIMATED"},"lastUpdateSubmitDate":"2011-06-09","lastUpdatePostDateStruct":{"date":"2011-06-10","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"oldNameTitle":"Katsuhisa Saito","oldOrganization":"OPCJ"},"leadSponsor":{"name":"Otsuka Pharmaceutical Co., Ltd.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The purpose of this study is to investigate the efficacy of cilostazol in preventing recurrence of cerebral infarction and the safety of long-term administration of the drug (100 mg, twice daily) in patients with cerebral infarction (excluding cardiogenic cerebral embolism) in a multi-center, double-blind, parallel-group comparison with aspirin (81 mg, once daily)."},"conditionsModule":{"conditions":["Cerebral Infarction"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":2800,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"1","type":"EXPERIMENTAL","description":"cilostazol","interventionNames":["Drug: Cilostazol"]},{"label":"2","type":"ACTIVE_COMPARATOR","description":"Aspirin","interventionNames":["Drug: Aspirin"]}],"interventions":[{"type":"DRUG","name":"Cilostazol","description":"oral tablet, 100 mg twice a day and placebo of aspirin once a day, 1 to 5years","armGroupLabels":["1"]},{"type":"DRUG","name":"Aspirin","description":"oral tablet, placebo of cilostazol twice a day and 81 mg once a day, 1 to 5 years","armGroupLabels":["2"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Numbers of Patients With First Occurence of Stroke","description":"The endpoint in this measure is a composite endpoint of the first recurrence of cerebral infarction, or occurrence of cerebral haemorrhage or subarachnoid haemorrhage. The evaluation committee, whose members were unaware of patients' treatment assignment, adjudicated all trial endpoints.","timeFrame":"From start of treatment to end of follow-up period ( follow-up periods : 29 months [Standard Deviation 16, range 1-59 months])"}],"secondaryOutcomes":[{"measure":"Number of Patients With First Recurrence of Cerebral Infarction","timeFrame":"From start of treatment to end of follow-up period (mean follow-up periods : 29 months [STANDARD DEVIATION 16, range 1-59 months])"},{"measure":"Number of Patients With First Occurrence of Ischaemic Cerebrovascular Disease","description":"The endpoint in this measure is a composite endpoint of the first recurrence of cerebral infarction or the first occurrence of transient ischaemic attack. The evaluation committee, whose members were unaware of patients' treatment assignment, adjudicated all trial endpoints.","timeFrame":"From start of treatment to end of follow-up period ( follow-up periods : 29 months [STANDARD DEVIATION 16, range 1-59 months])"},{"measure":"Number of Deaths From Any Cause","description":"Number of deaths from any cause. The evaluation committee, whose members were unaware of patients' treatment assignment, adjudicated all trial endpoints.","timeFrame":"From start of treatment to end of follow-up period ( follow-up periods : 29 months [STANDARD DEVIATION 16, range 1-59 months])"},{"measure":"Number of Patients With First Occurrence of a Composite Endpoint of Stroke, Haemorrhagic Events, or Cardiovascular Events","description":"The endpoint in this measure is a composite endpoint of the first recurrence of cerebral infarction, or occurrence of cerebral haemorrhage, subarachnoid haemorrhage, transient ischaemic attack, angina pectris, myocardial infarction, heart failure, or haemorrhage requiring hospital admission. The evaluation committee, whose members were unaware of patients' treatment assignment, adjudicated all trial endpoints.","timeFrame":"From start of treatment to end of follow-up period ( follow-up periods : 29 months [STANDARD DEVIATION 16, range 1-59 months])"}],"otherOutcomes":[{"measure":"Number of Patients With First Occurrence of Haemorrhagic Event","description":"The endpoint in this measure is a composite endpoint of the first occurrence of cerebral haemorrhage, subarachnoid haemorrhage or haemorrhage requiring hospital admission. The evaluation committee, whose members were unaware of patients' treatment assignment, adjudicated all trial endpoints.","timeFrame":"From start of treatment to end of follow-up period ( follow-up periods : 29 months [STANDARD DEVIATION 16, range 1-59 months])"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Patients with stable medical conditions for 182 days (26 weeks) after occurrence of cerebral infarction\n2. Patients in whom the infarct-related foci was detected by X-ray CT scan or MRI\n3. Patients aged 20 to 80 years (inclusive) at time of consent\n4. Patients with none of the following cardiac diseases that may be associated with cardiogenic cerebral embolism: mitral stenosis, prosthetic heart valve, endocarditis, myocardial infarction within 6 weeks after occurrence, ventricular aneurysm, endocardial thrombosis, mitral valve prolapse (patients less than 45 years of age in whom no other cause was identified), atrial fibrillation, sick sinus syndrome, idiopathic cardiomyopathy, and patent foramen ovale\n5. Patients without asymptomatic cerebral infarction\n6. Patients who have neither undergone nor are scheduled to undergo percutaneous transluminal angioplasty or revascularization for the treatment of cerebral infarction\n7. Patients without severe disturbances/impairments following occurrence of cerebral\n\nExclusion Criteria:\n\n1. Patients with hemorrhage or bleeding tendency (hemophilia, capillary fragility, intracranial hemorrhage, hemorrhage in the digestive tract, hemorrhage in the urinary tract, hemoptysis, and hemorrhage in the vitreous body)\n2. Pregnant, possibly pregnant, or nursing women\n3. Patients with ischemic heart failure\n4. Patients with peptic ulcer\n5. Patients with severer blood disorders\n6. Patients with severe hepatic or renal\n7. Patients with malignant neoplasm or patients who have received any therapy for malignant neoplasm within 5 years prior to entering the study\n8. Patients with a history of hypersensitivity to salicylic acid formulations or ingredients of cilostazol tablets\n9. Patients with aspirin asthma (asthma attacks induced by nonsteroidal antiinflammatory analgesic agents) or a history of aspirin asthma\n10. Patients who are being treated with ticlopidine hydrochloride\n11. Patients who are participating in another study for an investigational drug\n12. Patients who are otherwise judged inappropriate for inclusion in the study by the investigators","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Masahiko Abe","affiliation":"Division of New Product Evaluation and Development","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Otsuka Pharmaceutical Co., Ltd.","city":"Tokyo","country":"Japan","geoPoint":{"lat":35.6895,"lon":139.69171}}]},"referencesModule":{"references":[{"pmid":"20833591","type":"RESULT","citation":"Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, Ohashi Y, Tanahashi N, Yamamoto H, Genka C, Kitagawa Y, Kusuoka H, Nishimaru K, Tsushima M, Koretsune Y, Sawada T, Hamada C; CSPS 2 group. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol. 2010 Oct;9(10):959-68. doi: 10.1016/S1474-4422(10)70198-8. Epub 2010 Sep 15."}]}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"No screening period","recruitmentDetails":"Patients with non-cardioembolic ischemic stroke have been recruited at 278 study sites in Japan between December, 2003, and October, 2006.","groups":[{"id":"FG000","title":"Cilostazol","description":"cilostazol, oral tablet, 100 mg cilostazol"},{"id":"FG001","title":"Aspirin","description":"Aspirin, oral tablet, 81 mg aspirin"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"1356"},{"groupId":"FG001","numSubjects":"1360"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"881"},{"groupId":"FG001","numSubjects":"1004"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"475"},{"groupId":"FG001","numSubjects":"356"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"268"},{"groupId":"FG001","numSubjects":"166"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"73"},{"groupId":"FG001","numSubjects":"56"}]},{"type":"Physician Decision","reasons":[{"groupId":"FG000","numSubjects":"23"},{"groupId":"FG001","numSubjects":"22"}]},{"type":"Not Classified","reasons":[{"groupId":"FG000","numSubjects":"111"},{"groupId":"FG001","numSubjects":"112"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Cilostazol","description":"cilostazol, oral tablet, 100 mg cilostazol"},{"id":"BG001","title":"Aspirin","description":"Aspirin, oral tablet, 81 mg aspirin"},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"1337"},{"groupId":"BG001","value":"1335"},{"groupId":"BG002","value":"2672"}]}],"measures":[{"title":"Age, Categorical","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"<=18 years","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Between 18 and 65 years","measurements":[{"groupId":"BG000","value":"681"},{"groupId":"BG001","value":"685"},{"groupId":"BG002","value":"1366"}]},{"title":">=65 years","measurements":[{"groupId":"BG000","value":"656"},{"groupId":"BG001","value":"650"},{"groupId":"BG002","value":"1306"}]}]}]},{"title":"Age Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"63.5","spread":"9.2"},{"groupId":"BG001","value":"63.4","spread":"9.0"},{"groupId":"BG002","value":"63.4","spread":"9.1"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"378"},{"groupId":"BG001","value":"378"},{"groupId":"BG002","value":"756"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"959"},{"groupId":"BG001","value":"957"},{"groupId":"BG002","value":"1916"}]}]}]},{"title":"Region of Enrollment","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":"Japan","categories":[{"measurements":[{"groupId":"BG000","value":"1337"},{"groupId":"BG001","value":"1335"},{"groupId":"BG002","value":"2672"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Numbers of Patients With First Occurence of Stroke","description":"The endpoint in this measure is a composite endpoint of the first recurrence of cerebral infarction, or occurrence of cerebral haemorrhage or subarachnoid haemorrhage. The evaluation committee, whose members were unaware of patients' treatment assignment, adjudicated all trial endpoints.","populationDescription":"Analyses were done using the full analysis set (FAS) of patients, as predetermined in the protocol. The full analysis set excluded patients who failed to satisfy inclusion criteria and those who violated exclusion criteria.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"From start of treatment to end of follow-up period ( follow-up periods : 29 months [Standard Deviation 16, range 1-59 months])","groups":[{"id":"OG000","title":"Cilostazol","description":"cilostazol, oral tablet, 100 mg cilostazol"},{"id":"OG001","title":"Aspirin","description":"Aspirin, oral tablet, 81 mg aspirin"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1337"},{"groupId":"OG001","value":"1335"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"119"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"Statistical Analysis 1 for Number of Patients With First Occurrence of Stroke","testedNonInferiority":true,"nonInferiorityType":"NON_INFERIORITY_OR_EQUIVALENCE","nonInferiorityComment":"If the upper 95% CI limit for the HR of cilostazol to aspirin was 1.33 (4/3) or lower , cilostazol would be non-inferior to aspirin.","pValue":"0.0357","pValueComment":"The log-rank test was used to verify the superiority of CLZ to ASA only if non-inferiority was verified. The adjusted significance level for the superiority test of the endpoint was set at 0.0471 (two-tailed) according to the O'Brien-Fleming method.","statisticalMethod":"Log Rank","paramType":"Hazard Ratio, log","paramValue":"0.743","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.564","ciUpperLimit":"0.981"}]},{"type":"SECONDARY","title":"Number of Patients With First Recurrence of Cerebral Infarction","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"From start of treatment to end of follow-up period (mean follow-up periods : 29 months [STANDARD DEVIATION 16, range 1-59 months])","groups":[{"id":"OG000","title":"Cilostazol","description":"cilostazol, oral tablet, 100 mg cilostazol"},{"id":"OG001","title":"Aspirin","description":"Aspirin, oral tablet, 81 mg aspirin"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1337"},{"groupId":"OG001","value":"1335"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"88"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"Analyses were done using the full analysis set (FAS) of patients, as predetermined in the protocol. The full analysis set excluded patients who failed to satisfy inclusion criteria and those who violated exclusion criteria.","testedNonInferiority":false,"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.4189","statisticalMethod":"Log Rank","paramType":"Hazard Ratio, log","paramValue":"0.88","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.645","ciUpperLimit":"1.200"}]},{"type":"SECONDARY","title":"Number of Patients With First Occurrence of Ischaemic Cerebrovascular Disease","description":"The endpoint in this measure is a composite endpoint of the first recurrence of cerebral infarction or the first occurrence of transient ischaemic attack. The evaluation committee, whose members were unaware of patients' treatment assignment, adjudicated all trial endpoints.","populationDescription":"Analyses were done using the full analysis set (FAS) of patients, as predetermined in the protocol. The full analysis set excluded patients who failed to satisfy inclusion criteria and those who violated exclusion criteria.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"From start of treatment to end of follow-up period ( follow-up periods : 29 months [STANDARD DEVIATION 16, range 1-59 months])","groups":[{"id":"OG000","title":"Cilostazol","description":"cilostazol, oral tablet, 100 mg cilostazol"},{"id":"OG001","title":"Aspirin","description":"Aspirin, oral tablet, 81 mg aspirin"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1337"},{"groupId":"OG001","value":"1335"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"86"},{"groupId":"OG001","value":"103"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"Analyses were done using the full analysis set (FAS) of patients, as predetermined in the protocol. The full analysis set excluded patients who failed to satisfy inclusion criteria and those who violated exclusion criteria.","testedNonInferiority":false,"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.4582","statisticalMethod":"Log Rank","paramType":"Hazard Ratio (HR)","paramValue":"0.898","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.675","ciUpperLimit":"1.194"}]},{"type":"SECONDARY","title":"Number of Deaths From Any Cause","description":"Number of deaths from any cause. The evaluation committee, whose members were unaware of patients' treatment assignment, adjudicated all trial endpoints.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"From start of treatment to end of follow-up period ( follow-up periods : 29 months [STANDARD DEVIATION 16, range 1-59 months])","groups":[{"id":"OG000","title":"Cilostazol","description":"cilostazol, oral tablet, 100 mg cilostazol"},{"id":"OG001","title":"Aspirin","description":"Aspirin, oral tablet, 81 mg aspirin"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1337"},{"groupId":"OG001","value":"1335"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"13"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"Analyses were done using the full analysis set (FAS) of patients, as predetermined in the protocol. The full analysis set excluded patients who failed to satisfy inclusion criteria and those who violated exclusion criteria.","testedNonInferiority":false,"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.8600","statisticalMethod":"Log Rank","paramType":"Hazard Ratio (HR)","paramValue":"1.072","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.497","ciUpperLimit":"2.313"}]},{"type":"SECONDARY","title":"Number of Patients With First Occurrence of a Composite Endpoint of Stroke, Haemorrhagic Events, or Cardiovascular Events","description":"The endpoint in this measure is a composite endpoint of the first recurrence of cerebral infarction, or occurrence of cerebral haemorrhage, subarachnoid haemorrhage, transient ischaemic attack, angina pectris, myocardial infarction, heart failure, or haemorrhage requiring hospital admission. The evaluation committee, whose members were unaware of patients' treatment assignment, adjudicated all trial endpoints.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"From start of treatment to end of follow-up period ( follow-up periods : 29 months [STANDARD DEVIATION 16, range 1-59 months])","groups":[{"id":"OG000","title":"Cilostazol","description":"cilostazol, oral tablet, 100 mg cilostazol"},{"id":"OG001","title":"Aspirin","description":"Aspirin, oral tablet, 81 mg aspirin"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1337"},{"groupId":"OG001","value":"1335"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"138"},{"groupId":"OG001","value":"186"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"Analyses were done using the full analysis set (FAS) of patients, as predetermined in the protocol. The full analysis set excluded patients who failed to satisfy inclusion criteria and those who violated exclusion criteria.","testedNonInferiority":false,"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.0437","statisticalMethod":"Log Rank","paramType":"Hazard Ratio (HR)","paramValue":"0.799","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.643","ciUpperLimit":"0.994"}]},{"type":"OTHER_PRE_SPECIFIED","title":"Number of Patients With First Occurrence of Haemorrhagic Event","description":"The endpoint in this measure is a composite endpoint of the first occurrence of cerebral haemorrhage, subarachnoid haemorrhage or haemorrhage requiring hospital admission. The evaluation committee, whose members were unaware of patients' treatment assignment, adjudicated all trial endpoints.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"From start of treatment to end of follow-up period ( follow-up periods : 29 months [STANDARD DEVIATION 16, range 1-59 months])","groups":[{"id":"OG000","title":"Cilostazol","description":"cilostazol, oral tablet, 100 mg cilostazol"},{"id":"OG001","title":"Aspirin","description":"Aspirin, oral tablet, 81 mg aspirin"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1337"},{"groupId":"OG001","value":"1335"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"57"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"Analyses were done using the full analysis set (FAS) of patients, as predetermined in the protocol. The full analysis set excluded patients who failed to satisfy inclusion criteria and those who violated exclusion criteria.","testedNonInferiority":false,"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.0004","statisticalMethod":"Log Rank","paramType":"Hazard Ratio (HR)","paramValue":"0.458","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.296","ciUpperLimit":"0.711"}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"From start of treatment to end of follow-up period (mean follow-up periods : 29 months [STANDARD DEVIATION 16, range 1-59 months])","eventGroups":[{"id":"EG000","title":"Cilostazol","description":"cilostazol, oral tablet, 100 mg cilostazol","seriousNumAffected":372,"seriousNumAtRisk":1337,"otherNumAffected":1267,"otherNumAtRisk":1337},{"id":"EG001","title":"Aspirin","description":"Aspirin, oral tablet, 81 mg aspirin","seriousNumAffected":433,"seriousNumAtRisk":1335,"otherNumAffected":1260,"otherNumAtRisk":1335}],"seriousEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":5,"numAtRisk":1335}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Anaemia macrocytic","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Disseminated intravascular coagulation","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Hypochromic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Iron deficiency anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Lymphadenopathy","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Angina pectoris","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":1337},{"groupId":"EG001","numAffected":6,"numAtRisk":1335}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":1337},{"groupId":"EG001","numAffected":7,"numAtRisk":1335}]},{"term":"Cardiac failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Angina unstable","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Cardiac failure acute","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Ventricular extrasystoles","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Myocardial ischaemia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Prinzmetal angina","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Intracardiac thrombus","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Stress cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Aortic valve stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Atrial flutter","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Atrioventricular block complete","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Atrioventricular block second degree","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Coronary artery stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Silent myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Hydrocele","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Intestinal malrotation","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Vertigo","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Vertigo positional","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Sudden hearing loss","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Meniere's disease","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Vertigo labyrinthine","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Cataract","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":22,"numAtRisk":1337},{"groupId":"EG001","numAffected":17,"numAtRisk":1335}]},{"term":"Macular oedema","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Cataract subcapsular","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Diabetic retinal oedema","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Pterygium","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Vitreous haemorrhage","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Entropion","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Ulcerative keratitis","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Amaurosis","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Cataract diabetic","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Diabetic retinopathy","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Macular degeneration","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Retinal detachment","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Retinal haemorrhage","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Retinal vein occlusion","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Macular hole","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Tolosa-Hunt syndrome","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Inguinal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":1337},{"groupId":"EG001","numAffected":5,"numAtRisk":1335}]},{"term":"Colonic polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":1337},{"groupId":"EG001","numAffected":7,"numAtRisk":1335}]},{"term":"Gastric ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Enterocolitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Haemorrhoids","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Hiatus hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Periodontitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Reflux oesophagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Anal fistula","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Colitis ischaemic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Diverticulum intestinal haemorrhagic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Gastric polyps","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Gastric ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":9,"numAtRisk":1335}]},{"term":"Gastrointestinal disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Ileus","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Ileus paralytic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Mallory-Weiss syndrome","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Melaena","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Pancreatitis acute","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Peritonitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Large intestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Diverticulitis intestinal haemorrhagic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Duodenal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Duodenal ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Food poisoning","organSystem":"General disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Gastritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Gastritis erosive","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Gastroduodenal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Gingival hyperplasia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Large intestinal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Upper gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Lower gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Varices oesophageal","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Disuse syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Granuloma","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Sudden death","organSystem":"General disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Mass","organSystem":"General disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Cardiac death","organSystem":"General disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Gait disturbance","organSystem":"General disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Hepatic function abnormal","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Bile duct stone","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Cholangitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Autoimmune hepatitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Cholecystitis acute","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Liver disorder","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Biliary cirrhosis primary","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Hepatic cirrhosis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Jaundice cholestatic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":1337},{"groupId":"EG001","numAffected":9,"numAtRisk":1335}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Herpes zoster","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Pyelonephritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Pyelonephritis acute","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Enteritis infectious","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Appendicitis perforated","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Bronchopneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Diverticulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Herpes virus infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Postoperative wound infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Retroperitoneal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Viral infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Anal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Postoperative abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Extradural abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Osteomyelitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Pelvic abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Pseudomembranous colitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Varicella","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Anogenital warts","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Pneumonia bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Pneumocystis jiroveci pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Enterocolitis bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Femoral neck fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Spinal compression fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Subdural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Facial bones fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Hand fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Humerus fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Rib fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Ankle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Carbon monoxide poisoning","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Femur fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Multiple fractures","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Spinal cord injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Tendon rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Cervical vertebral fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Lumbar vertebral fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Muscle strain","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Thermal burn","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Eye injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Pelvic fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Upper limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Renal injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Lower limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Burns third degree","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Clavicle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Compression fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Extradural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Foot fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Forearm fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Head injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Joint dislocation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Joint sprain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Open fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Radius fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Road traffic accident","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Subcutaneous haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Tibia fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Brain contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Meniscus lesion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Skin laceration","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Skull fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Limb traumatic amputation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Blood urea increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Blood glucose increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Blood pressure increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Blood glucose fluctuation","organSystem":"Investigations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Blood creatine phosphokinase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Blood potassium increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Platelet count decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":1337},{"groupId":"EG001","numAffected":6,"numAtRisk":1335}]},{"term":"Hypoglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Anorexia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Diabetes mellitus inadequate control","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Hyperglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Hypoalbuminaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Malnutrition","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Type 2 diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Back pain","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Arthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Rotator cuff syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Temporomandibular joint syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Intervertebral disc protrusion","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Spinal ligament ossification","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Lumbar spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Muscle haemorrhage","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Periostitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Rhabdomyolysis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Spinal osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Tenosynovitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Axillary mass","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Spondylolisthesis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Gastric cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":1337},{"groupId":"EG001","numAffected":8,"numAtRisk":1335}]},{"term":"Large intestine carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Lung neoplasm malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Brain neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Bladder cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Colon cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Pancreatic carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Colon adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Thyroid cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Bladder papilloma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Carcinoid tumour of the gastrointestinal tract","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Hepatic neoplasm malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Laryngeal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Lung adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Malignant ascites","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Malignant neoplasm of renal pelvis","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Metastases to liver","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Neoplasm skin","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Oesophageal carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Rectal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Renal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Thyroid neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Small intestine carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Gastric adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Prostate cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Metastatic neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Salivary gland neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Spinal cord neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Renal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Adenoma benign","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Bowen's disease","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Breast cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Cervix carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Haemangioma of liver","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Kaposi's sarcoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Lipoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Liposarcoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Metastases to lymph nodes","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Small cell lung cancer stage unspecified","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Thyroid adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Ureteric cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Uterine cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Salivary gland adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Pancreatic carcinoma stage IV","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Adrenal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Metastatic gastric cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":62,"numAtRisk":1337},{"groupId":"EG001","numAffected":84,"numAtRisk":1335}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":1337},{"groupId":"EG001","numAffected":9,"numAtRisk":1335}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":1337},{"groupId":"EG001","numAffected":6,"numAtRisk":1335}]},{"term":"Cerebral haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":1337},{"groupId":"EG001","numAffected":25,"numAtRisk":1335}]},{"term":"Epilepsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Loss of consciousness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Facial palsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Subarachnoid haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Convulsion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Dementia Alzheimer's type","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Haemorrhagic cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Hypoaesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Hypoglycaemic coma","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Intraventricular haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Paralysis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Presenile dementia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Ruptured cerebral aneurysm","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Vertebral artery stenosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Reversible ischaemic neurological deficit","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Thalamus haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Putamen haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Thrombotic cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Amyotrophic lateral sclerosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Carotid artery stenosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Cerebellar haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Cervicobrachial syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Dysarthria","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Myelopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Petit mal epilepsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Sciatica","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Vertebral artery occlusion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Delirium","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Anxiety disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Completed suicide","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Suicide attempt","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Alcoholism","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Dissociative disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Mania","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Adjustment disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Calculus bladder","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Calculus ureteric","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Calculus urethral","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Hydronephrosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Nephrolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Renal failure acute","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Bladder prolapse","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Acute prerenal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Calculus urinary","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Glomerulonephritis rapidly progressive","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Haematuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Nephritis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Proteinuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Renal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Urinary retention","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Renal impairment","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Benign prostatic hyperplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Uterine prolapse","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Prostatitis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Pneumonia aspiration","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":1337},{"groupId":"EG001","numAffected":2,"numAtRisk":1335}]},{"term":"Haemoptysis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Haemothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Interstitial lung disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Emphysema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Nasal polyps","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Diaphragmatic disorder","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Asphyxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":4,"numAtRisk":1335}]},{"term":"Nasal congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Pleurisy","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Pneumothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Status asthmaticus","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Upper respiratory tract inflammation","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Drug eruption","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Neurodermatitis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Hypoaesthesia facial","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Skin mass","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Shock haemorrhagic","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Aortic aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]},{"term":"Aortic aneurysm rupture","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Varicose vein","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":3,"numAtRisk":1335}]},{"term":"Arteriosclerosis obliterans","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1337},{"groupId":"EG001","numAffected":0,"numAtRisk":1335}]},{"term":"Peripheral artery aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1337},{"groupId":"EG001","numAffected":1,"numAtRisk":1335}]}],"otherEvents":[{"term":"Palpitations","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":156,"numAtRisk":1337},{"groupId":"EG001","numAffected":71,"numAtRisk":1335}]},{"term":"Tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":89,"numAtRisk":1337},{"groupId":"EG001","numAffected":21,"numAtRisk":1335}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":164,"numAtRisk":1337},{"groupId":"EG001","numAffected":85,"numAtRisk":1335}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":110,"numAtRisk":1337},{"groupId":"EG001","numAffected":155,"numAtRisk":1335}]},{"term":"Dental caries","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":93,"numAtRisk":1337},{"groupId":"EG001","numAffected":114,"numAtRisk":1335}]},{"term":"Periodontitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":77,"numAtRisk":1337},{"groupId":"EG001","numAffected":64,"numAtRisk":1335}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":546,"numAtRisk":1337},{"groupId":"EG001","numAffected":590,"numAtRisk":1335}]},{"term":"Contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":128,"numAtRisk":1337},{"groupId":"EG001","numAffected":121,"numAtRisk":1335}]},{"term":"Blood glucose increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":92,"numAtRisk":1337},{"groupId":"EG001","numAffected":79,"numAtRisk":1335}]},{"term":"Blood pressure increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":71,"numAtRisk":1337},{"groupId":"EG001","numAffected":88,"numAtRisk":1335}]},{"term":"Blood creatine phosphokinase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":67,"numAtRisk":1337},{"groupId":"EG001","numAffected":76,"numAtRisk":1335}]},{"term":"Diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":96,"numAtRisk":1337},{"groupId":"EG001","numAffected":75,"numAtRisk":1335}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":160,"numAtRisk":1337},{"groupId":"EG001","numAffected":165,"numAtRisk":1335}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":118,"numAtRisk":1337},{"groupId":"EG001","numAffected":102,"numAtRisk":1335}]},{"term":"Musculoskeletal pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":73,"numAtRisk":1337},{"groupId":"EG001","numAffected":55,"numAtRisk":1335}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":312,"numAtRisk":1337},{"groupId":"EG001","numAffected":217,"numAtRisk":1335}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":124,"numAtRisk":1337},{"groupId":"EG001","numAffected":92,"numAtRisk":1335}]},{"term":"Insomnia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":81,"numAtRisk":1337},{"groupId":"EG001","numAffected":96,"numAtRisk":1335}]},{"term":"Upper respiratory tract inflammation","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":97,"numAtRisk":1337},{"groupId":"EG001","numAffected":105,"numAtRisk":1335}]},{"term":"Eczema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":97,"numAtRisk":1337},{"groupId":"EG001","numAffected":104,"numAtRisk":1335}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Ver.12.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":120,"numAtRisk":1337},{"groupId":"EG001","numAffected":185,"numAtRisk":1335}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"Masahiko Abe, Director Cardiovascular Projects","organization":"Department of Clinical Research and Development, Otsuka Pharmaceutical Co., Ltd.","email":"abems@otsuka.jp","phone":"+81-6-6943-7722","phoneExt":"2545"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007238","term":"Infarction"}],"ancestors":[{"id":"D000007511","term":"Ischemia"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000009336","term":"Necrosis"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000020521","term":"Stroke"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M14540","name":"Recurrence","relevance":"LOW"},{"id":"M9972","name":"Infarction","asFound":"Infarction","relevance":"HIGH"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Cerebral Infarction","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000001241","term":"Aspirin"},{"id":"D000077407","term":"Cilostazol"}],"ancestors":[{"id":"D000000894","term":"Anti-Inflammatory Agents, Non-Steroidal"},{"id":"D000018712","term":"Analgesics, Non-Narcotic"},{"id":"D000000700","term":"Analgesics"},{"id":"D000018689","term":"Sensory System Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000000893","term":"Anti-Inflammatory Agents"},{"id":"D000018501","term":"Antirheumatic Agents"},{"id":"D000005343","term":"Fibrinolytic Agents"},{"id":"D000050299","term":"Fibrin Modulating Agents"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000010975","term":"Platelet Aggregation Inhibitors"},{"id":"D000016861","term":"Cyclooxygenase Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000058633","term":"Antipyretics"},{"id":"D000001993","term":"Bronchodilator Agents"},{"id":"D000001337","term":"Autonomic Agents"},{"id":"D000018927","term":"Anti-Asthmatic Agents"},{"id":"D000019141","term":"Respiratory System Agents"},{"id":"D000014665","term":"Vasodilator Agents"},{"id":"D000018696","term":"Neuroprotective Agents"},{"id":"D000020011","term":"Protective Agents"},{"id":"D000058987","term":"Phosphodiesterase 3 Inhibitors"},{"id":"D000010726","term":"Phosphodiesterase Inhibitors"}],"browseLeaves":[{"id":"M4238","name":"Aspirin","asFound":"Knee","relevance":"HIGH"},{"id":"M1788","name":"Cilostazol","asFound":"Stored","relevance":"HIGH"},{"id":"M3907","name":"Anti-Inflammatory Agents","relevance":"LOW"},{"id":"M3908","name":"Anti-Inflammatory Agents, Non-Steroidal","relevance":"LOW"},{"id":"M3722","name":"Analgesics","relevance":"LOW"},{"id":"M20476","name":"Analgesics, Non-Narcotic","relevance":"LOW"},{"id":"M20294","name":"Antirheumatic Agents","relevance":"LOW"},{"id":"M8163","name":"Fibrinolytic Agents","relevance":"LOW"},{"id":"M13555","name":"Platelet Aggregation Inhibitors","relevance":"LOW"},{"id":"M18899","name":"Cyclooxygenase Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"M28866","name":"Antipyretics","relevance":"LOW"},{"id":"M4959","name":"Bronchodilator Agents","relevance":"LOW"},{"id":"M20653","name":"Anti-Asthmatic Agents","relevance":"LOW"},{"id":"M20827","name":"Respiratory System Agents","relevance":"LOW"},{"id":"M17102","name":"Vasodilator Agents","relevance":"LOW"},{"id":"M20463","name":"Neuroprotective Agents","relevance":"LOW"},{"id":"M21559","name":"Protective Agents","relevance":"LOW"},{"id":"M29023","name":"Phosphodiesterase 3 Inhibitors","relevance":"LOW"},{"id":"M13319","name":"Phosphodiesterase Inhibitors","relevance":"LOW"}],"browseBranches":[{"abbrev":"Antipy","name":"Antipyretics"},{"abbrev":"Infl","name":"Anti-Inflammatory Agents"},{"abbrev":"ARhu","name":"Antirheumatic Agents"},{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"Analg","name":"Analgesics"},{"abbrev":"PlAggInh","name":"Platelet Aggregation Inhibitors"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"VaDiAg","name":"Vasodilator Agents"},{"abbrev":"NeuroAg","name":"Neuroprotective Agents"},{"abbrev":"Resp","name":"Respiratory System Agents"}]}},"hasResults":true}